Drug Discovery

Revolutionizing Surgery: DIP Technology in 3D Bioprinting
Biotech & Bioprocessing Revolutionizing Surgery: DIP Technology in 3D Bioprinting

3D printing technology is paving the way for significant advancements in the medical field, particularly within plastic and reconstructive surgery. The introduction of dynamic interface printing (DIP) promises to transform tissue engineering, making it possible to create patient-specific,

Why Are Hedge Funds Investing Big in AI and MedTech Healthcare?
Management & Regulatory Why Are Hedge Funds Investing Big in AI and MedTech Healthcare?

The fourth quarter of 2024 witnessed a significant surge in hedge fund investments focused on the healthcare sector, particularly emphasizing advancements in artificial intelligence (AI), biotechnology, and medical technology (MedTech). This pivotal period showcased growing confidence among

CROs Shift to Alternative Methods Following FDA Animal Testing Phase-Out
Research & Development CROs Shift to Alternative Methods Following FDA Animal Testing Phase-Out

Chinese contract research organization GemPharmatech has expanded its presence in the United States with a new facility in San Diego, announced on April 17. The facility is designed for laboratories and housing genetically engineered mouse models, aimed at enhancing their capabilities in offering

Can Glycomine's $115M Funded Drug Transform Rare Disease Treatment?
Tech & Innovation Can Glycomine's $115M Funded Drug Transform Rare Disease Treatment?

Glycomine, a leading biotechnology company based in San Francisco, has achieved a notable milestone by raising $115 million in funding for their pioneering project, GLM101. This development is particularly significant in an economic environment where securing substantial capital remains

How Are Innovations in Medicine and Nanotech Changing Lives?
Tech & Innovation How Are Innovations in Medicine and Nanotech Changing Lives?

Ivan Kairatov is a distinguished figure in the biopharma industry, renowned for his expertise in tech and innovation within the field. With a robust background in research and development, Ivan has substantially influenced advancements in cellular therapies and drug development. Today, we delve

FDA Grants Fast Track to Verve's VERVE-102 for Heart Disease
Research & Development FDA Grants Fast Track to Verve's VERVE-102 for Heart Disease

Verve Therapeutics has announced a significant advancement in genetic medicine as their investigational drug VERVE-102 receives Fast Track designation from the U.S. Food and Drug Administration (FDA). This approval marks a crucial step in the development of treatments for hyperlipidemia and

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later